MetaADEDB 2.0 @ LMMD
Caspofungin
(OGUJBRYAAJYXQP-IJFZAWIJSA-N)
Structure
SMILES
CC(=O)O.CC(=O)O.NCCN[C@H]1NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@H](C[C@H]1O)NC(=O)CCCCCCCC[C@H](C[C@H](CC)C)C)[C@H](O)C)C[C@@H](C2)O)[C@@H]([C@H](c1ccc(cc1)O)O)O)[C@@H](CCN)O
Molecular Formula:
C56H96N10O19
Molecular Weight:
1213.420
Log P:
0.2433
Hydrogen Bond Acceptor:
29
Hydrogen Bond Donor:
18
TPSA:
486.63
CAS Number(s):
179463-17-3
Synonym(s)
1.
Caspofungin
2.
Cancidas
3.
Caspofungin Acetate
4.
Caspofungin MSD
5.
L 743,872
6.
L 743872
7.
L-743,872
8.
L-743872
9.
MK 0991
10.
MK-0991
11.
L743,872
12.
L743872
13.
MK0991
External Link(s)
MeSHD000077336
PubChem Compound117065245
16119813
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Acute graft versus host disease in intestineOFFSIDES
3Acute graft versus host disease in liverOFFSIDES
4Acute respiratory failureOFFSIDES
5AdenitisOFFSIDES
6Adverse eventOFFSIDES
7Alanine Aminotransferase IncreasedOFFSIDES
8Ammonia increasedOFFSIDES
9Anticholinergic SyndromeOFFSIDES
10Antithrombin III decreasedOFFSIDES
11AnuriaOFFSIDES
12AspergillomaOFFSIDES
13AspergillosisOFFSIDES
14Atrial thrombosisOFFSIDES
15B-cell lymphoma stage IIOFFSIDES
16Bacterial sepsisOFFSIDES
17Biliary FistulaOFFSIDES
18Bilirubin conjugated increasedOFFSIDES
19Blast cell count increasedOFFSIDES
20Blood alkaline phosphatase increasedOFFSIDES
21Blood calcium abnormalOFFSIDES
22Blood creatine phosphokinase abnormalOFFSIDES
23Blood lactate dehydrogenase increasedOFFSIDES
24Blood magnesium decreasedOFFSIDES
25Blood osmolarity decreasedOFFSIDES
26Blood pH decreasedOFFSIDES
27Blood sodium increasedOFFSIDES
28Blood urea increasedOFFSIDES
29Blood uric acid decreasedOFFSIDES
30Body TemperatureOFFSIDES
31Brain AbscessOFFSIDES
32Bronchoalveolar LavageOFFSIDES
33Candida sepsisOFFSIDES
34Candidiasis of vaginaOFFSIDES
35Capillary Leak SyndromeOFFSIDES
36Cardioactive drug levelOFFSIDES
37Carnitine deficiencyOFFSIDES
38Catheter bacteraemiaOFFSIDES
39Catheter site inflammationOFFSIDES
40Cerebral aspergillosisOFFSIDES
41Cerebral hypoperfusionOFFSIDES
42Cervical laser therapyOFFSIDES
43CheilitisOFFSIDES
44CholangiolitisOFFSIDES
45Chronic granulomatous diseaseOFFSIDES
46Chronic respiratory failureOFFSIDES
47Circumstance or information capable of leading to medication errorOFFSIDES
48Clostridium difficile colitisOFFSIDES
49Coagulation factor V level decreasedOFFSIDES
50Culture positiveOFFSIDES
51Cytolytic hepatitisOFFSIDES
52Delayed engraftmentOFFSIDES
53Device related infectionOFFSIDES
54Dilatation intrahepatic duct acquiredOFFSIDES
55Disease ProgressionOFFSIDES
56Drug ineffectiveOFFSIDES
57Drug resistanceOFFSIDES
58Electromechanical dissociationOFFSIDES
59Embolic strokeOFFSIDES
60Endocarditis enterococcalOFFSIDES
61EndocarditisOFFSIDES
62EndometriosisOFFSIDES
63Enterococcal infectionOFFSIDES
64Enterococcal sepsisOFFSIDES
65EnterocolitisOFFSIDES
66Eosinophilic myocarditisOFFSIDES
67EpilepsyOFFSIDES
68Familial Mediterranean FeverOFFSIDES
69Febrile NeutropeniaOFFSIDES
70Febrile bone marrow aplasiaOFFSIDES
71Focal Nodular HyperplasiaOFFSIDES
72Fungus culture positiveOFFSIDES
73Gamma-Glutamyltransferase IncreasedOFFSIDES
74Gastrointestinal stoma complicationOFFSIDES
75General physical health deteriorationOFFSIDES
76GranulocytosisOFFSIDES
77Haptoglobin DecreasedOFFSIDES
78HemiplegiaOFFSIDES
79Hepatic infection fungalOFFSIDES
80Hepatic necrosisOFFSIDES
81Hepatic siderosisOFFSIDES
82Hepatitis B positiveOFFSIDES
83HepatitisOFFSIDES
84Hepatosplenic candidiasisOFFSIDES
85HepatosplenomegalyOFFSIDES
86HepatotoxicityOFFSIDES
87Histiocytosis haematophagicOFFSIDES
88HydropneumothoraxOFFSIDES
89Hypocoagulable stateOFFSIDES
90Immunosuppressant drug level decreasedOFFSIDES
91Incorrect drug dosage form administeredOFFSIDES
92InfectionOFFSIDES
93Infusion site rashOFFSIDES
94Intestinal FistulaOFFSIDES
95JC virus infectionOFFSIDES
96Kidney FailureOFFSIDES
97Klebsiella sepsisOFFSIDES
98Large intestine perforationOFFSIDES
99Leukopenia neonatalOFFSIDES
100Liver AbscessOFFSIDES
101Lung infection pseudomonalOFFSIDES
102Lymphocyte percentage decreasedOFFSIDES
103Mixed liver injuryOFFSIDES
104MucormycosisOFFSIDES
105Multi-organ disorderOFFSIDES
106Muscle necrosisOFFSIDES
107Myocarditis mycoticOFFSIDES
108Myoclonic EpilepsyOFFSIDES
109Myoglobin urine presentOFFSIDES
110Myositis OssificansOFFSIDES
111Neurological decompensationOFFSIDES
112Neurological examination abnormalOFFSIDES
113OliguriaOFFSIDES
114PancreatitisOFFSIDES
115Paroxysmal arrhythmiaOFFSIDES
116Pathogen resistanceOFFSIDES
117PeritonitisOFFSIDES
118PhlebitisOFFSIDES
119Platelet count abnormalOFFSIDES
120PneumopericardiumOFFSIDES
121PolyneuropathyOFFSIDES
122Prescribed overdoseOFFSIDES
123Prothrombin time abnormalOFFSIDES
124Pseudomonal sepsisOFFSIDES
125Red blood cell schistocytes presentOFFSIDES
126Refusal of treatment by relativeOFFSIDES
127Renal abscessOFFSIDES
128Renal tubular disorderOFFSIDES
129Respiratory FailureOFFSIDES
130RetinitisOFFSIDES
131Retroperitoneal abscessOFFSIDES
132Salpingo-oophorectomyOFFSIDES
133Scedosporium infectionOFFSIDES
134Septic ShockOFFSIDES
135Septic embolusOFFSIDES
136Sinus bradycardiaOFFSIDES
137SoporOFFSIDES
138Splenic InfarctionOFFSIDES
139Status EpilepticusOFFSIDES
140Stenotrophomonas infectionOFFSIDES
141Stevens-Johnson SyndromeOFFSIDES
142Superinfection bacterialOFFSIDES
143Systemic mycosisOFFSIDES
144T-cell lymphoma stage IIIOFFSIDES
145Therapy non-responderOFFSIDES
146Therapy responderOFFSIDES
147Torulopsis infectionOFFSIDES
148ToxoplasmosisOFFSIDES
149Transaminases increasedOFFSIDES
150Trichosporon infectionOFFSIDES
151Unresponsive to stimuliOFFSIDES
152VasospasmOFFSIDES
153Venoocclusive diseaseOFFSIDES
154Venous occlusionOFFSIDES
155Venous stent insertionOFFSIDES
156Ventricular FibrillationOFFSIDES
157treatment failureOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.